These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 19996349

  • 1. Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial.
    Minasian C, Wallis C, Metcalfe C, Bush A.
    Thorax; 2010 Jan; 65(1):51-6. PubMed ID: 19996349
    [Abstract] [Full Text] [Related]

  • 2. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ, Thornton J, Murray CS, Dwyer T.
    Cochrane Database Syst Rev; 2020 May 01; 5(5):CD008649. PubMed ID: 32358807
    [Abstract] [Full Text] [Related]

  • 3. Inhaled mannitol for cystic fibrosis.
    Nolan SJ, Thornton J, Murray CS, Dwyer T.
    Cochrane Database Syst Rev; 2015 Oct 09; (10):CD008649. PubMed ID: 26451533
    [Abstract] [Full Text] [Related]

  • 4. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ, Thornton J, Murray CS, Dwyer T.
    Cochrane Database Syst Rev; 2018 Feb 09; 2(2):CD008649. PubMed ID: 29424930
    [Abstract] [Full Text] [Related]

  • 5. Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.
    De Boeck K, Haarman E, Hull J, Lands LC, Moeller A, Munck A, Riethmüller J, Tiddens H, Volpi S, Leadbetter J, Charlton B, Malfroot A, DPM-CF-204 Study Group.
    J Cyst Fibros; 2017 May 09; 16(3):380-387. PubMed ID: 28258928
    [Abstract] [Full Text] [Related]

  • 6. Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis.
    Robinson M, Hemming AL, Moriarty C, Eberl S, Bye PT.
    Pediatr Pulmonol; 2000 Jul 09; 30(1):16-24. PubMed ID: 10862158
    [Abstract] [Full Text] [Related]

  • 7. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial.
    Suri R, Metcalfe C, Lees B, Grieve R, Flather M, Normand C, Thompson S, Bush A, Wallis C.
    Lancet; 2001 Oct 20; 358(9290):1316-21. PubMed ID: 11684212
    [Abstract] [Full Text] [Related]

  • 8. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
    Laube BL, Auci RM, Shields DE, Christiansen DH, Lucas MK, Fuchs HJ, Rosenstein BJ.
    Am J Respir Crit Care Med; 1996 Feb 20; 153(2):752-60. PubMed ID: 8564129
    [Abstract] [Full Text] [Related]

  • 9. Inhaled mannitol for the treatment of cystic fibrosis.
    Hurt K, Bilton D.
    Expert Rev Respir Med; 2012 Feb 20; 6(1):19-26. PubMed ID: 22283575
    [Abstract] [Full Text] [Related]

  • 10. Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis.
    Minasian C, Wallis C, Metcalfe C, Bush A.
    Pediatr Pulmonol; 2008 Nov 20; 43(11):1078-1084. PubMed ID: 18972410
    [Abstract] [Full Text] [Related]

  • 11. Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study.
    Bilton D, Robinson P, Cooper P, Gallagher CG, Kolbe J, Fox H, Jaques A, Charlton B, CF301 Study Investigators.
    Eur Respir J; 2011 Nov 20; 38(5):1071-80. PubMed ID: 21478216
    [Abstract] [Full Text] [Related]

  • 12. Inhaled mannitol and cystic fibrosis. Unnecessary bronchial irritation.
    Prescrire Int; 2014 Apr 20; 23(148):89-91. PubMed ID: 24860889
    [Abstract] [Full Text] [Related]

  • 13. Inhaled Dry Powder Mannitol Treatment in Pediatric Patients with Cystic Fibrosis: Evaluation of Clinical Data in a Real-World Setting.
    Duman I, Ünal G, Yilmaz AI, Güney AY, Durduran Y, Pekcan S.
    Pediatr Allergy Immunol Pulmonol; 2022 Mar 20; 35(1):19-26. PubMed ID: 35285672
    [Abstract] [Full Text] [Related]

  • 14. Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis.
    Henry RL, Gibson PG, Carty K, Cai Y, Francis JL.
    Pediatr Pulmonol; 1998 Aug 20; 26(2):97-100. PubMed ID: 9727759
    [Abstract] [Full Text] [Related]

  • 15. Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis.
    Suri R, Grieve R, Normand C, Metcalfe C, Thompson S, Wallis C, Bush A.
    Thorax; 2002 Oct 20; 57(10):841-6. PubMed ID: 12324668
    [Abstract] [Full Text] [Related]

  • 16. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.
    Aitken ML, Bellon G, De Boeck K, Flume PA, Fox HG, Geller DE, Haarman EG, Hebestreit HU, Lapey A, Schou IM, Zuckerman JB, Charlton B, CF302 Investigators.
    Am J Respir Crit Care Med; 2012 Mar 15; 185(6):645-52. PubMed ID: 22198974
    [Abstract] [Full Text] [Related]

  • 17. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
    Bilton D, Tino G, Barker AF, Chambers DC, De Soyza A, Dupont LJ, O'Dochartaigh C, van Haren EH, Vidal LO, Welte T, Fox HG, Wu J, Charlton B, B-305 Study Investigators.
    Thorax; 2014 Dec 15; 69(12):1073-9. PubMed ID: 25246664
    [Abstract] [Full Text] [Related]

  • 18. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME.
    N Engl J Med; 1994 Sep 08; 331(10):637-42. PubMed ID: 7503821
    [Abstract] [Full Text] [Related]

  • 19. RhDNase before airway clearance therapy improves airway patency in children with CF.
    van der Giessen LJ, de Jongste JC, Gosselink R, Hop WC, Tiddens HA.
    Pediatr Pulmonol; 2007 Jul 08; 42(7):624-30. PubMed ID: 17534979
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.